OBJECTIVE: To investigate the feasibility of primary coronary angioplasty as a treatment option in patients with acute myocardial infarction after initial diagnosis in a local community hospital. SETTING: Referral centre for interventional treatment of coronary artery disease. METHODS: During a five year period, 520 candidates for primary coronary angioplasty were treated in our institution, 104 after transfer from a community hospital. The transferred patients and the non-transferred patients (n = 416) were compared with regard to baseline clinical characteristics, time interval from symptom onset to treatment, and clinical outcome at six months. RESULTS: In this setting, the influence of transportation on total ischaemic time was limited, and there was no difference in clinical outcome between the transferred and the non-transferred patients. Clinical outcome was mainly dependent on the indication for transfer. CONCLUSIONS: Safe and expedient transportation may facilitate the more widespread use of primary angioplasty in patients with acute myocardial infarction. A large randomised multicentre trial is needed to compare the relative merits of intravenous thrombolytic treatment in a local hospital with primary angioplasty after transfer in selected high risk patients with acute myocardial infarction.
OBJECTIVE: To investigate the feasibility of primary coronary angioplasty as a treatment option in patients with acute myocardial infarction after initial diagnosis in a local community hospital. SETTING: Referral centre for interventional treatment of coronary artery disease. METHODS: During a five year period, 520 candidates for primary coronary angioplasty were treated in our institution, 104 after transfer from a community hospital. The transferred patients and the non-transferred patients (n = 416) were compared with regard to baseline clinical characteristics, time interval from symptom onset to treatment, and clinical outcome at six months. RESULTS: In this setting, the influence of transportation on total ischaemic time was limited, and there was no difference in clinical outcome between the transferred and the non-transferred patients. Clinical outcome was mainly dependent on the indication for transfer. CONCLUSIONS: Safe and expedient transportation may facilitate the more widespread use of primary angioplasty in patients with acute myocardial infarction. A large randomised multicentre trial is needed to compare the relative merits of intravenous thrombolytic treatment in a local hospital with primary angioplasty after transfer in selected high risk patients with acute myocardial infarction.
Authors: R L Bellinger; R M Califf; D B Mark; R A Weber; P Collins; J Stone; H R Phillips; L German; R S Stack Journal: Am J Cardiol Date: 1988-04-01 Impact factor: 2.778
Authors: C L Grines; K F Browne; J Marco; D Rothbaum; G W Stone; J O'Keefe; P Overlie; B Donohue; N Chelliah; G C Timmis Journal: N Engl J Med Date: 1993-03-11 Impact factor: 91.245
Authors: B R Brodie; R A Weintraub; T D Stuckey; E J LeBauer; J D Katz; T A Kelly; C J Hansen Journal: Am J Cardiol Date: 1991-01-01 Impact factor: 2.778
Authors: J M Gore; C B Granger; M L Simoons; M A Sloan; W D Weaver; H D White; G I Barbash; F Van de Werf; P E Aylward; E J Topol Journal: Circulation Date: 1995-11-15 Impact factor: 29.690
Authors: N Ernst; M-J de Boer; F Zijlstra; H Suryapranata; J-H E Dambrink; J C A Hoorntje; A W J van 't Hof Journal: Neth Heart J Date: 2006-02 Impact factor: 2.380
Authors: F Vermeer; A J Oude Ophuis; E J vd Berg; L G Brunninkhuis; C J Werter; A G Boehmer; A H Lousberg; W R Dassen; F W Bär Journal: Heart Date: 1999-10 Impact factor: 5.994
Authors: N M S K J Ernst; M J de Boer; A W J van 't Hof; F Hollak; H van de Wetering; J H E Dambrink; J C A Hoorntje; H Suryapranata; F Zijlstra Journal: Neth Heart J Date: 2004-04 Impact factor: 2.380
Authors: Pria M D Nippak; Jodie Pritchard; Robin Horodyski; Candace J Ikeda-Douglas; Winston W Isaac Journal: BMC Health Serv Res Date: 2014-10-01 Impact factor: 2.655
Authors: John M Westfall; Catarina I Kiefe; Norman W Weissman; Anthony Goudie; Robert M Centor; O Dale Williams; Jeroan J Allison Journal: BMC Cardiovasc Disord Date: 2008-09-09 Impact factor: 2.298